Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

NCT: NCT06345963 · RECRUITING

NCT IDNCT06345963
StatusRECRUITING
Start Date2024-05-21
Completion2030-05-01
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from H coil for improving white matter integrity.

Frequently Asked Questions

What is Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)?

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) is a clinical trial registered under NCT06345963. Current status: RECRUITING.

What is the status of NCT06345963?

The current status of NCT06345963 (Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)) is: RECRUITING.

When did Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) start?

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) started on 2024-05-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.